49 medicines lose their last listed patent or exclusivity in 2026.
January6 medicines
- Promactaeltrombopag olamine · Novartis Pharmaceuticals Corp
- Promacta Kiteltrombopag olamine · Novartis Pharmaceuticals Corp
- Soluprep Schlorhexidine gluconate and isopropyl alcohol · Solventum US LLC
- Primatene Mistepinephrine · Armstrong Pharmaceuticals Inc
- Revatio · Solution (intravenous)sildenafil citrate · Viatris Specialty LLC
- Revatio · For suspension (oral)sildenafil citrate · Viatris Specialty LLC
February3 medicines
March5 medicines
- Arnuity Elliptafluticasone furoate · Glaxosmithkline Intellectual Property Development Ltd England
- Naproxen Sodiumnaproxen sodium · Bionpharma Inc
- Pradaxadabigatran etexilate mesylate · Boehringer Ingelheim Pharmaceuticals Inc
- Rextovynaloxone hydrochloride · Amphastar Pharmaceuticals Inc
- Coreg CRcarvedilol phosphate · Waylis Therapeutics LLC
April5 medicines
May3 medicines
June6 medicines
- Emflaza · Tablet (oral)deflazacort · Ptc Therapeutics Inc
- Emflaza · Suspension (oral)deflazacort · Ptc Therapeutics Inc
- Cambiadiclofenac potassium · Cosette Pharmaceuticals Inc
- Supprelin LAhistrelin acetate · Endo Operations Ltd
- Aplenzinbupropion hydrobromide · Bausch Health US LLC
- Thiolatiopronin · Mission Pharmacal Co
July6 medicines
- Fycompa · Tablet (oral)perampanel · Catalyst Pharmaceuticals Inc
- Fycompa · Suspension (oral)perampanel · Catalyst Pharmaceuticals Inc
- Opillnorgestrel · Laboratoire Hra Pharma
- Spirivatiotropium bromide · Boehringer Ingelheim Pharmaceuticals Inc
- Aktenlidocaine hydrochloride · Thea Pharma Inc
- Omegavenfish oil triglycerides · Fresenius Kabi USA LLC
August4 medicines
- Nuedextadextromethorphan hydrobromide and quinidine sulfate · Otsuka America Pharmaceutical Inc
- Tekturnaaliskiren hemifumarate · Lxo Ireland Designated Activity Co
- Gallium Ga 68 Edotreotidegallium GA-68 edotreotide · Univ Iowa Hosps and Clinics Pet Imaging Center
- Dymistaazelastine hydrochloride and fluticasone propionate · Mylan Specialty LP